NCT00002122View on ClinicalTrials.gov

A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

720

Participants

Timeline

Start Date

Not specified

Conditions
MycosesMycobacterium Avium-Intracellulare InfectionHIV Infections
Interventions
DRUG

Azithromycin

DRUG

Rifabutin

DRUG

Fluconazole

Trial Locations (12)

19104

Univ of Pennsylvania, Philadelphia

20007

Georgetown Univ Med Ctr, Washington D.C.

20037

George Washington Univ Med Ctr, Washington D.C.

75235

Univ of Texas Southwestern Med Ctr, Dallas

77005

Baylor College of Medicine, Houston

77030

Houston Veterans Administration Med Ctr, Houston

90033

Los Angeles County - USC Med Ctr, Los Angeles

90509

Harbor - UCLA Med Ctr, Torrance

92103

UCSD Treatment Ctr / Dept of Medicine and Pediatrics, San Diego

92668

UCI Med Ctr, Orange

951282699

Santa Clara Valley Med Ctr, San Jose

01655

Univ of Massachusetts Med Ctr, Worcester

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00002122 - A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients | Biotech Hunter | Biotech Hunter